{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:56:35Z","timestamp":1740149795473,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12288-022-01535-z","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T12:04:09Z","timestamp":1649678649000},"page":"675-679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-resolution Melting Analysis for NOTCH1 c.7541-7542delCT Mutation in Chronic Lymphocytic Leukemia: Prognostic Significance in Egyptian Patients"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1046-643X","authenticated-orcid":false,"given":"Dalia","family":"Sherief","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Habeeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahla","family":"Nosair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaly","family":"Mabrouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Shoeib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Reyad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer","family":"Haydra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Watany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"issue":"4","key":"1535_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1182\/blood-2015-02-585042","volume":"126","author":"R Gui\u00e8ze","year":"2015","unstructured":"Gui\u00e8ze R, Wu CJ (2015) Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia. Blood 126(4):445\u2013453 (PMID: 26065654)","journal-title":"Blood"},{"issue":"1","key":"1535_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.beha.2016.08.005","volume":"29","author":"CI Amaya-Chanaga","year":"2016","unstructured":"Amaya-Chanaga CI, Rassenti LZ (2016) Biomarkers in chronic lymphocytic leukemia: clinical applications and prognostic markers. Best Pract Res Clin Haematol 29(1):79\u201389 (PMID: 27742074)","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"1535_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1124\/molpharm.120.000006","volume":"98","author":"L Gharaibeh","year":"2020","unstructured":"Gharaibeh L, Elmadany N, Alwosaibai K et al (2020) Notch1 in cancer therapy: possible clinical implications and challenges. Mol Pharmacol 98(5):559\u2013576 (PMID: 32913140)","journal-title":"Mol Pharmacol"},{"issue":"8","key":"1535_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fonc.2018.00229.PMID:29998084;PMCID:PMC6030253","volume":"27","author":"E Rosati","year":"2018","unstructured":"Rosati E, Baldoni S, De Falco F, Del Papa B, Dorillo E, Rompietti C, Albi E, Falzetti F, Di Ianni M, Sportoletti P (2018) NOTCH1 aberrations in chronic lymphocytic leukemia. Front Oncol 27(8):229. https:\/\/doi.org\/10.3389\/fonc.2018.00229.PMID:29998084;PMCID:PMC6030253","journal-title":"Front Oncol"},{"issue":"2","key":"1535_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3892\/ijmm.2017.2849","volume":"39","author":"JJ Xu","year":"2017","unstructured":"Xu JJ, Yao FR, Jiang M et al (2017) High-resolution melting analysis for rapid and sensitive NOTCH1 screening in chronic lymphocytic leukemia. Int J Mol Med 39(2):415\u2013422 (PMID: 28075457)","journal-title":"Int J Mol Med"},{"key":"1535_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.leukres.2017.08.001","volume":"60","author":"E Vavrova","year":"2017","unstructured":"Vavrova E, Kantorova B, Vonkova B et al (2017) Fragment analysis represents a suitable approach for the detection of hotspot c.7541_7542delCT NOTCH1 mutation in chronic lymphocytic leukemia. Leuk Res. 60:145\u2013150 (PMID: 28837890)","journal-title":"Leuk Res."},{"issue":"20","key":"1535_CR7","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"issue":"14","key":"1535_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2407-14-13","volume":"10","author":"MA Ihle","year":"2014","unstructured":"Ihle MA, Fassunke J, K\u00f6nig K et al (2014) Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations. BMC Cancer 10(14):13 (PMID: 24410877)","journal-title":"BMC Cancer"},{"issue":"3\u20134","key":"1535_CR9","first-page":"435","volume":"61","author":"H Zhang","year":"2015","unstructured":"Zhang H, Zhang X, Wang J et al (2015) Comparison of high-resolution melting analysis, sanger sequencing and ARMS for KRAS mutation detection in metastatic colorectal cancer. Clin Lab 61(3\u20134):435\u2013439 (PMID: 25975014)","journal-title":"Clin Lab"},{"issue":"6","key":"1535_CR10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/humu.21019","volume":"30","author":"RH Vossen","year":"2009","unstructured":"Vossen RH, Aten E, Roos A et al (2009) High-resolution melting analysis (HRMA): more than just sequence variant screening. Hum Mutat 30(6):860\u2013866 (PMID: 19418555)","journal-title":"Hum Mutat"},{"issue":"1","key":"1535_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/leu.2015.182","volume":"30","author":"F Pozzo","year":"2016","unstructured":"Pozzo F, Bittolo T, Arruga F et al (2016) NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation. Leukemia 30(1):182\u2013189 (PMID: 26165233)","journal-title":"Leukemia"},{"issue":"9","key":"1535_CR12","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/leu.2016.383","volume":"31","author":"F Arruga","year":"2017","unstructured":"Arruga F, Gizdic B, Bologna C et al (2017) Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22. Leukemia 31(9):1882\u20131893 (PMID: 28017968)","journal-title":"Leukemia"},{"issue":"3","key":"1535_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5045\/br.2020.2020080","volume":"55","author":"VK Srinivasan","year":"2020","unstructured":"Srinivasan VK, Naseem S, Varma N et al (2020) Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression. Blood Res 55(3):131\u2013138","journal-title":"Blood Res"},{"issue":"2","key":"1535_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","volume":"119","author":"D Rossi","year":"2012","unstructured":"Rossi D, Rasi S, Fabbri G et al (2012) Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 119(2):521\u2013529 (PMID: 22077063)","journal-title":"Blood"},{"key":"1535_CR15","unstructured":"Del Poeta G, Biagi A, Laurenti L et al. (2020) Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia. Haematologica. (PMID: 32732360)"},{"issue":"15","key":"1535_CR16","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1182\/blood-2013-10-534271","volume":"123","author":"M Messina","year":"2014","unstructured":"Messina M, Del Giudice I, Khiabanian H et al (2014) Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. Blood 123(15):2378\u20132388 (PMID: 24550227)","journal-title":"Blood"},{"issue":"5","key":"1535_CR17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/pbc.24852","volume":"61","author":"L Gallo Llorente","year":"2014","unstructured":"Gallo Llorente L, Luther H, Schneppenheim R et al (2014) Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway. Pediatr Blood Cancer 61(5):788\u2013796 (PMID: 24249312)","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1535_CR18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/leu.2017.296","volume":"32","author":"D Benedetti","year":"2018","unstructured":"Benedetti D, Tissino E, Pozzo F et al (2018) NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-\u03baB pathways. Leukemia 32(3):654\u2013662 (PMID: 28935990)","journal-title":"Leukemia"},{"issue":"1","key":"1535_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/leu.2014.143","volume":"29","author":"M L\u00f3pez-Guerra","year":"2015","unstructured":"L\u00f3pez-Guerra M, Xargay-Torrent S, Rosich L et al (2015) The \u03b3-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells. Leukemia 29(1):96\u2013106 (PMID: 24781018)","journal-title":"Leukemia"},{"issue":"1","key":"1535_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s13046-019-1458-7","volume":"38","author":"E Silkenstedt","year":"2019","unstructured":"Silkenstedt E, Arenas F, Colom-Sanmart\u00ed B et al (2019) Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy. J Exp Clin Cancer Res. 38(1):446 (PMID: 31676012)","journal-title":"J Exp Clin Cancer Res."},{"issue":"6","key":"1535_CR21","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41388-019-1053-6","volume":"39","author":"M L\u00f3pez-Guerra","year":"2020","unstructured":"L\u00f3pez-Guerra M, Xargay-Torrent S, Fuentes P et al (2020) Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells. Oncogene 39(6):1185\u20131197 (PMID: 31616059)","journal-title":"Oncogene"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-022-01535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12288-022-01535-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-022-01535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T20:07:51Z","timestamp":1665864471000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12288-022-01535-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1535"],"URL":"https:\/\/doi.org\/10.1007\/s12288-022-01535-z","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"type":"print","value":"0971-4502"},{"type":"electronic","value":"0974-0449"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"15 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors state no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The local Institutional Review Board deemed the study exempt from review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}